Literature DB >> 18723112

HIC1 (Hypermethylated in Cancer 1) epigenetic silencing in tumors.

Capucine Fleuriel1, Majid Touka, Gaylor Boulay, Cateline Guérardel, Brian R Rood, Dominique Leprince.   

Abstract

HIC1 (Hypermethylated in Cancer 1), as it name implied, was originally isolated as a new candidate tumor suppressor gene located at 17p13.3 because it resides in a CpG island that is hypermethylated in many types of human cancers. HIC1 encodes a transcription factor associating an N-terminal BTB/POZ domain to five C-terminal Krüppel-like C(2)H(2) zinc finger motifs. In this review, we will begin by providing an overview of the current knowledge on HIC1 function, mainly gained from in vitro studies, as a sequence-specific transcriptional repressor interacting with a still growing range of HDAC-dependent and HDAC-independent corepressor complexes. We will then summarize the studies that have demonstrated frequent hypermethylation changes or losses of heterozygosity of the HIC1 locus in human cancers. Next, we will review animal models which have firmly established HIC1 as a bona fide tumor suppressor gene epigenetically silenced and functionally cooperating notably with p53 within a complex HIC1-p53-SIRT1 regulatory loop. Finally, we will discuss how this epigenetic inactivation of HIC1 might "addict" cancer cells to altered survival and signaling pathways or to lineage-specific transcription factors during the early stages of tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18723112      PMCID: PMC2631403          DOI: 10.1016/j.biocel.2008.05.028

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  76 in total

Review 1.  DNA methylation changes in hematologic malignancies: biologic and clinical implications.

Authors:  J P Issa; S B Baylin; J G Herman
Journal:  Leukemia       Date:  1997-03       Impact factor: 11.528

Review 2.  p53: puzzle and paradigm.

Authors:  L J Ko; C Prives
Journal:  Genes Dev       Date:  1996-05-01       Impact factor: 11.361

3.  Poor correlation with loss of heterozygosity on chromosome 17p and p53 mutations in ovarian cancers.

Authors:  T Sakamoto; N Nomura; H Mori; N Wake
Journal:  Gynecol Oncol       Date:  1996-11       Impact factor: 5.482

4.  Cancer-specific region of hypermethylation identified within the HIC1 putative tumour suppressor gene in acute myeloid leukaemia.

Authors:  J R Melki; P C Vincent; S J Clark
Journal:  Leukemia       Date:  1999-06       Impact factor: 11.528

5.  Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia.

Authors:  J R Melki; P C Vincent; S J Clark
Journal:  Cancer Res       Date:  1999-08-01       Impact factor: 12.701

6.  DNA hypermethylation at the D17S5 locus and reduced HIC-1 mRNA expression are associated with hepatocarcinogenesis.

Authors:  Y Kanai; A M Hui; L Sun; S Ushijima; M Sakamoto; H Tsuda; S Hirohashi
Journal:  Hepatology       Date:  1999-03       Impact factor: 17.425

7.  The carboxy-terminal end of the candidate tumor suppressor gene HIC-1 is phylogenetically conserved.

Authors:  S Deltour; C Guerardel; D Stehelin; D Leprince
Journal:  Biochim Biophys Acta       Date:  1998-11-26

8.  Hypermethylation of chromosome 17P locus D17S5 in human prostate tissue.

Authors:  R A Morton; J J Watkins; G S Bova; M M Wales; S B Baylin; W B Isaacs
Journal:  J Urol       Date:  1996-08       Impact factor: 7.450

9.  p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3.

Authors:  M M Wales; M A Biel; W el Deiry; B D Nelkin; J P Issa; W K Cavenee; S J Kuerbitz; S B Baylin
Journal:  Nat Med       Date:  1995-06       Impact factor: 53.440

10.  Prognostic significance of loss of heterozygosity at loci on chromosome 17p13.3-ter in sporadic breast cancer is evidence for a putative tumour suppressor gene.

Authors:  D S Liscia; R Morizio; T Venesio; C Palenzona; M Donadio; R Callahan
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

View more
  44 in total

1.  Differential regulation of HIC1 target genes by CtBP and NuRD, via an acetylation/SUMOylation switch, in quiescent versus proliferating cells.

Authors:  Capucine Van Rechem; Gaylor Boulay; Sébastien Pinte; Nicolas Stankovic-Valentin; Cateline Guérardel; Dominique Leprince
Journal:  Mol Cell Biol       Date:  2010-06-14       Impact factor: 4.272

2.  Hypermethylated in cancer 1 (HIC1) recruits polycomb repressive complex 2 (PRC2) to a subset of its target genes through interaction with human polycomb-like (hPCL) proteins.

Authors:  Gaylor Boulay; Marion Dubuissez; Capucine Van Rechem; Antoine Forget; Kristian Helin; Olivier Ayrault; Dominique Leprince
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

Review 3.  Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties.

Authors:  Mahmoud Alhosin; Tanveer Sharif; Marc Mousli; Nelly Etienne-Selloum; Guy Fuhrmann; Valérie B Schini-Kerth; Christian Bronner
Journal:  J Exp Clin Cancer Res       Date:  2011-04-15

Review 4.  SIRT1 and p53, effect on cancer, senescence and beyond.

Authors:  Jingjie Yi; Jianyuan Luo
Journal:  Biochim Biophys Acta       Date:  2010-05-13

5.  Tandem repeat variation near the HIC1 (hypermethylated in cancer 1) promoter predicts outcome of oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.

Authors:  Satoshi Okazaki; Marta Schirripa; Fotios Loupakis; Shu Cao; Wu Zhang; Dongyun Yang; Yan Ning; Martin D Berger; Yuji Miyamoto; Mitsukuni Suenaga; Syma Iqubal; Afsaneh Barzi; Chiara Cremolini; Alfredo Falcone; Francesca Battaglin; Lisa Salvatore; Beatrice Borelli; Timothy G Helentjaris; Heinz-Josef Lenz
Journal:  Cancer       Date:  2017-07-14       Impact factor: 6.860

6.  Complex patterns of altered MicroRNA expression during the adenoma-adenocarcinoma sequence for microsatellite-stable colorectal cancer.

Authors:  Angela N Bartley; Hui Yao; Bedia A Barkoh; Cristina Ivan; Bal M Mishra; Asif Rashid; George A Calin; Rajyalakshmi Luthra; Stanley R Hamilton
Journal:  Clin Cancer Res       Date:  2011-09-23       Impact factor: 12.531

Review 7.  Epigenetics of neurological cancers.

Authors:  Shaun D Fouse; Joseph F Costello
Journal:  Future Oncol       Date:  2009-12       Impact factor: 3.404

8.  Developmentally programmed 3' CpG island methylation confers tissue- and cell-type-specific transcriptional activation.

Authors:  Da-Hai Yu; Carol Ware; Robert A Waterland; Jiexin Zhang; Miao-Hsueh Chen; Manasi Gadkari; Govindarajan Kunde-Ramamoorthy; Lagina M Nosavanh; Lanlan Shen
Journal:  Mol Cell Biol       Date:  2013-03-04       Impact factor: 4.272

9.  HIC1 modulates uveal melanoma progression by activating lncRNA-numb.

Authors:  Guangcun Cheng; Jie He; Leilei Zhang; Shengfang Ge; He Zhang; Xianqun Fan
Journal:  Tumour Biol       Date:  2016-07-23

10.  P53 induction accompanying G2/M arrest upon knockdown of tumor suppressor HIC1 in U87MG glioma cells.

Authors:  Sanjay Kumar
Journal:  Mol Cell Biochem       Date:  2014-07-04       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.